Point72 Asset Management, L.P.

Position in PRQR — ProQR Therapeutics N.V.

CIK 1603466 STAMFORD, CT

Position in PRQR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,224,464

-$419,109 QoQ

Shares Held

755,842

-7.1% QoQ

Ownership

0.536%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. PRQR ranks #115 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,224,464	755,842	-7.1%	Shares	Defined	2026-05-15
2025-12-31	$1,643,573	813,650	+8.5%	Shares	Defined	2026-02-17
2025-09-30	$1,597,500	750,000	0.0%	Shares	Defined	2025-11-14
2025-06-30	$1,530,000	750,000	0.0%	Shares	Defined	2025-08-14
2025-03-31	$997,500	750,000	-49.7%	Shares	Defined	2025-07-21
2024-12-31	$3,951,878	1,491,275	+223.5%	Shares	Defined	2025-02-14
2021-12-31	$3,692,610	461,000	+0.7%	Shares	Defined	2022-02-14
2021-09-30	$3,832,623	457,900	-69.9%	Shares	Defined	2021-11-15
2021-03-31	$10,059,098	1,521,800	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.